Phase 1 Study of Replication Competent Reovirus (Reolysin) in Combination With GM-CSF in Pediatric Patients With Relapsed or Refractory Brain Tumors
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Pelareorep (Primary) ; Sargramostim (Primary)
- Indications Astrocytoma; Brain cancer; Glioblastoma; Glioma; Medulloblastoma; Neuroectodermal tumours; Oligodendroglioma; Rhabdoid tumour
- Focus Adverse reactions
- 16 Mar 2018 Status changed from suspended to recruiting.
- 11 Oct 2017 Status changed from recruiting to suspended.
- 03 May 2016 Status changed from suspended to recruiting.